Modern conceptions of an uric acid role in development of essential hypertension
- 作者: Polovitkina O.1,2, Oshchepkova E.1,2, Dmitriev V.1,2, Titov V.1,2, Polovitkina O3, Oschepkova E3, Dmitriev V3, Titov V3
-
隶属关系:
- Институт клинической кардиологии им. А. Л. Мясникова
- ФГУ РКНПК
- Russian Research Cardiological Center, Moscow
- 期: 卷 83, 编号 8 (2011)
- 页面: 38-41
- 栏目: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/30889
- ID: 30889
如何引用文章
全文:
详细
作者简介
Ol'ga Polovitkina
Институт клинической кардиологии им. А. Л. Мясникова; ФГУ РКНПКаспирант лаб. профилактики артериальной гипертонии ИКК им. А. Л. Мясникова РКНПК, тел.: 8-495-414-61-63; Институт клинической кардиологии им. А. Л. Мясникова; ФГУ РКНПК
Elena Oshchepkova
Институт клинической кардиологии им. А. Л. Мясникова; ФГУ РКНПКд-р мед. наук, проф., рук. лаб. профилактики артериальной гипертонии ИКК им. А. Л. Мясникова РКНПК, тел.: 8-495-414-66-63; Институт клинической кардиологии им. А. Л. Мясникова; ФГУ РКНПК
Viktor Dmitriev
Институт клинической кардиологии им. А. Л. Мясникова; ФГУ РКНПК
Email: vicdmi@mail.ru
канд. мед. наук, науч. сотр. лаб. профилактики артериальной гипертонии ИКК им. А. Л. Мясникова РКНПК, тел.: 8-495-414-61-63; Институт клинической кардиологии им. А. Л. Мясникова; ФГУ РКНПК
Vladimir Titov
Институт клинической кардиологии им. А. Л. Мясникова; ФГУ РКНПКд-р мед. наук, проф., рук. лаб. клинической биохимии ИКК им. А. Л. Мясникова РКНПК, тел.: 8-495-414-63-10; Институт клинической кардиологии им. А. Л. Мясникова; ФГУ РКНПК
O Polovitkina
Russian Research Cardiological Center, MoscowRussian Research Cardiological Center, Moscow
E Oschepkova
Russian Research Cardiological Center, MoscowRussian Research Cardiological Center, Moscow
V Dmitriev
Russian Research Cardiological Center, MoscowRussian Research Cardiological Center, Moscow
V Titov
Russian Research Cardiological Center, MoscowRussian Research Cardiological Center, Moscow
参考
- Pillinger M. H., Rosenthal P. Hyperuricaemia and gout: new insights into pathogenesis and treatment. Bull. N. Y. Univ. Hosp. Jt. Dis. 2007; 66 (3): 215-221.
- Mahomed F. A. On chronic bright's disease and its essential symptoms. Lancet 1879; 1: 399-401.
- Huchard H. Allgemiene Betrachtungen uber die Arteriosklerose. Klin. Med. 1909; 5: 1318-1321.
- Duffy W. B., Senekjian H. O., Knight T. F., Weinman E. J. Management of asymptomatic hyperuricemia. J. A. M. A. 1981; 246: 2215-2216.
- Nakagava T., Tuttle K. R., Short R. A. et al. Fructose-induced hyperuricemia as a casual mechanism for the epidemic of the metabolic syndrome. Nat. Clin. Рract. Nephrol. 2005; 1: 80- 86.
- Niskanen L. K., Laaksonen D. E., Nyyssönen K. et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-age men: a prospective cohort study. Arch. Intern. Med. 2004; 164: 1546-1551.
- Verdechia P., Schilaci G., Reboldi G. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension 2000; 36: 1072- 1078.
- Band F. N., McGee D. L., Kennel W. B. Hyperuricemia as a risk factor of coronary heart disease: the Framinghem Heart Study. Am. J. Epidemiol. 1985; 121 (1): 11-18.
- Fang J., Alderman M. N. Serum uric acid and cardiovascular mortality: The NHANES I epidemiologic Follow-up study 1971-1992. National health and nutrition examination survey. J. A. M. A. 2000; 238 (18): 2404-2410.
- Alper A. B., Chen W., Yau L. et al. Childhood uric acid predicts adulthood blood pressure: The Bogalusa Heart Study. Hypertension 2005; 45: 33-38.
- Perlstein T. S., Guminiak O. Uric acid and the development of hypertension: The Normative Aging Study. Hypertension 2006; 48: 1031-1036.
- Sundstrom J., Sullivan L. Relation of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension 2005; 45: 28-33.
- Lurbe E., Torres C., Torro I. et al. Uric acid and cardiovascular risk factors in adolescent. In: 19th European meeting on hypertension, Milan, June 12-16, 2009: Milan; 2009. P. 9. 242; S 104.
- Faig D. L., Johnson R. J. Hyperuricemia in childhood primary hypertension. Hypertension 2003; 42: 247-252.
- Krishnan E., Kent Kwoh C., Schumacher H. R. et al. Hyperuricemia and Incidence of hypertension among men without metabolic syndrome. Hypertension 2007; 49: 298-303.
- Feig D. I., Soletsky B., Johnson R. J. Effect on blood pressure of adolescents with new diagnosed essential hypertension: a randomized trial. J. A. M. A. 2008; 300 (8): 924-932.
- Viazzi F, Parodi D, Leoncini G. Serum uric acid and target organ damage in primary hypertension. Hypertension 2005; 45: 991-996.
- Ощепкова E. B., Дмитриев B. A., Половиткина О. В., Титов В. Н. Содержание мочевой кислоты и ее роль на ранних стадиях гипертонической болезни. Систем. гипертенз. 2009; 2: 51-54.
- Nemirska A., Sladovska J., Antoniewicz J. et al. Uric acid concentration, metabolic syndrome components and target organ damage in adolescents and adults with essential hypertension. In: European meeting on hypertension, Milan, June 15-19, 2007. Milan; 2007. P37. 193; S346-S347.
- Hermida R. C., Chayan L., Ayala D. E. et al. Association of metabolic syndrome and blood pressure nondipping profile in untreated hypertension. Am. J. Hypertens. 2009; 22 (3): 307- 313.
- Afsar B., Elsurer R., Ozdemir F. N. et al. Uric acid and nocturnal nondiping in hypertensive patients with normal renal function. J. Nephrol. 2008; 21 (3): 406-411.
- Forman J. P., Choi H., Curhan G. C. Plasma uric acid level and risk for incident hypertension among men. J. Am. Soc. Nephrol. 2007; 18: 287-292.
- Mazzali M., Hughes J., Yoon-Goo Kim et al. Elevated uric acid increases blood pressure in the rats by a novel Crystal - Independent mechanism. Hypertension 2001; 38: 1101-1106.
- Sanches-Lozada L. G., Tapia E., Avia-Casado C. et al. Mild hyperuricemia induces glomerular hypertension in normal rats. Am. J. Physiol. Renal Physiol. 2002; 283: F1105-F1110.
- Watanabe S., Kang D. H., Feng L. et al. Uric acid, hominoid evolution and the pathogenesis salt-sensivity. Hypertension 2002; 40: 355-360.
- Nakagawa T., Mazzali M., Duk-Hee Kang et al. Hyperuricemia causes glomerular hypertrophy in the rat. Am. J. Nephrol. 2003; 23: 2-7.
- Bellomo G., Berardi P., Saronio P. et al. Microalbuminuria and uric acid in healthy subjects. J,. Nephrol. 2006; 19: 458-464.
- Jung Eun Lee, Yoon-Goo Kim, Choi Y. Serum uric acid is associated with microalbuminuria in prehypertension. Hypertension 2006;47: 962-967.
- Viazzi F., Parodi D., Leoncini G. Serum uric acid and target organ damage in primary hypertension. Hypertension 2005; 45: 991-996.
- Мухин Н. А., Балкаров И. М., Шоничев Д. Г. и др. Формирование артериальной гипертонии при уратном тубулоинтерстициальном поражении почек. Тер. арх. 1999; 6: 23- 27.
- Мухин Н. А., Моисеев В. С., Кобалава Ж. Д. и др. Кардиоренальные взаимодействия: клиническое значение и роль в патогенезе заболеваний сердечно-сосудистой системы и почек. Тер. арх. 2004; 6: 39-46.
- Serban С., Susan L., Pacurari A. et al. Association between serum uric acid levels and atherosclerosis in hypertensive patients. In: 19th European meeting on hypertension, Milan, June 12-16, 2009. Milan; 2009. P 23. 218; S 249.
- Zoccali C., Maio R., Mallamaci F. et al. Uric acid and endothelial dysfunction in essential hypertension. J. Аm. Soс. Nephrol. 2006; 17: 1466-1471.
- Khosla U. M., Zharikov S., Finch J. L. et al. Hyperuricemia induces endothelial dysfunction. Kidney 2005; 67 (5): 1739- 1742.
- Corry D. B., Eslami P., Yamamoto K. et al. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angioterisin system. J. Hypertens. 2008; 26: 269-275.
- Rao G. N., Corson M. A., Berk В. С. Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J. Biol. Chem. 1991; 266: 8604-8608.
- Netea M. G., Rullberg B. J., Blok W. L. et al. The role of Hyperuricemia in the increased cytokine production after lipopolisaccharide challenge in neutropenic mice. Blood. 1997; 89: 577-582.
- Mazzali M., Kanellis J., Han L., Feng L. Hyperuricemia induces a primarily renal arteriolopathy in rats by a blood pressure -independent mechanism. Am. J. Physiol. Renal Physiol. 2002; 289: 991-997.
- Kanellis J., Watanabe S., Jin H. Li et al. Uric acid stimulates monocyte chemoattractant rpotein-1 production in vascular smooth muscle cells via mitogen-activated proteinkinase and cylooxigenase-2. Hypertension 2003; 421: 1287-1293.
- Zalba G., Jose G., Moreno M. et al. Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension 2001; 38: 1395-1399.
- Kang D. H., Park S. K., Lee I. K. et al. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J. Am. Soc. Nephrol. 2005;16: 3553-3562.
- Hink H. U., Suntanan N., Dikalov S. et al. Peroxidase properties of extracellular superoxid dismutase: role of uric acid in modulating in vivo activity. Arterioscler. Thromb. Vasc. Biol. 2002; 22: 1402-1408.
- Pittaras A., Kokkinos P., Singh S. et al. Non-dippers have higher incidence of abnormal cardiac structure and function and less favorable lipid, glucose uric acid profile in pre-hypertensive and hypertensive men. J. Hypertens. 2006; 24 (Suppl. 4): S116.
- wshima Y., Horio T. Uric acid, left ventricular mass index and risk of cardiovascular disease in essential hypertension. Hypertension 2006; 47: 195-202.
- Valerio C., Cuspidi C., Sala С. et al. Lack of association between serum uric acid and organ damage in a never treated essential hypertensive population at low prevalence of hyperuricemia. In: European meeting on hypertension, Milan, June 15-19, 2007: Milan; 2007. P11. 273; S97-S98.